{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:06:51Z","timestamp":1789650411845,"version":"4.0.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T00:00:00Z","timestamp":1482278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T00:00:00Z","timestamp":1482278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00431-016-2830-7","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T23:44:37Z","timestamp":1482277477000},"page":"233-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":151,"title":["Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates"],"prefix":"10.1007","volume":"176","author":[{"given":"Abd El-Rahman","family":"El-Mashad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"El-Mahdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"El Amrousy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,21]]},"reference":[{"key":"2830_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1515\/JPM.2005.030","volume":"33","author":"S Alagarsamy","year":"2005","unstructured":"Alagarsamy S, Chhabra M, Gudavalli M, Nadroo AM, Sutija VG, Yugrakh D (2005) Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants. J Perinat Med 33:161\u2013164","journal-title":"J Perinat Med"},{"key":"2830_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000352068","volume":"104","author":"S Alan","year":"2013","unstructured":"Alan S, Kahyecioglu D, Erdeve O, Atasay B, Arsan S (2013) Is paracetamol a useful treatment for ibuprofen resistant patent ductus arteriosus? Neonatology 104:168\u2013169","journal-title":"Neonatology"},{"key":"2830_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00228-004-0756-x","volume":"60","author":"K Allegaert","year":"2004","unstructured":"Allegaert K, Anderson BJ, Naulaers G, de Hoon J, Verbesselt R, Debeer A, Devliegar H, Tibboel D (2004) Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm babies. Eur J Clin Pharmacol 60:191\u2013197","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2830_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1460-9592.2008.02680.x","volume":"19","author":"BJ Anderson","year":"2009","unstructured":"Anderson BJ, Allegaert K (2009) Intravenous neonatal paracetamol dosing: the magic of 10\u00a0days. Paediatr Anaesth 19(4):289\u2013295","journal-title":"Paediatr Anaesth"},{"key":"2830_CR5","first-page":"e778","volume":"8","author":"D Dang","year":"2013","unstructured":"Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H (2013) Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS One 8:e778\u2013e788","journal-title":"PLoS One"},{"issue":"2","key":"2830_CR6","first-page":"1","volume":"3","author":"C Dani","year":"2014","unstructured":"Dani C (2014) Ibuprofen and paracetamol for patent ductus arteriosus. J Pediatr Neonat Individual Med 3(2):1\u20134","journal-title":"J Pediatr Neonat Individual Med"},{"key":"2830_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13312-015-0677-z","volume":"52","author":"SK Dash","year":"2015","unstructured":"Dash SK, Kabra NS, Avashthi BS, Sharma SR, Padhi P, Ahmed J (2015) Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: a randomized controlled study. Indian Pediatr 52:573\u2013578","journal-title":"Indian Pediatr"},{"issue":"6","key":"2830_CR8","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1542\/peds.2011-0359","volume":"128","author":"C Hammerman","year":"2001","unstructured":"Hammerman C, Bin-nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D (2001) Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics 128(6):1618\u20131621","journal-title":"Pediatrics"},{"issue":"4","key":"2830_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.siny.2006.02.009","volume":"11","author":"E Jacqz-Aigrain","year":"2006","unstructured":"Jacqz-Aigrain E, Anderson BJ (2006) Pain control: nonsteroidal anti-inflammatory agents. Semin Fetal Neonatal Med 11(4):251\u2013259","journal-title":"Semin Fetal Neonatal Med"},{"key":"2830_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1023\/B:CAIM.0000041933.61896.55","volume":"20","author":"SL Jan","year":"2004","unstructured":"Jan SL, Hwang B, YC F, Chi CS (2004) Prediction of ductus arteriosus closure by neonatal screening echocardiography. Int J Cardiovasc Imaging 20:349\u2013356","journal-title":"Int J Cardiovasc Imaging"},{"key":"2830_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ultrasmedbio.2004.10.006","volume":"31","author":"WT Jim","year":"2005","unstructured":"Jim WT, Chiu NC, Chen MR, Hung HY, Kao HA, Hsu CH, Chang JH (2005) Cerebral hemodynamic change and intraventricular hemorrhage in very low birth weight infants with patent ductus arteriosus. Ultrasound Med Biol 31:197\u2013202","journal-title":"Ultrasound Med Biol"},{"issue":"3","key":"2830_CR12","first-page":"135","volume":"164","author":"LJ Jones","year":"2010","unstructured":"Jones LJ, Craven PD, Attia J, Thakkinstian A, Wright I (2010) Network meta-analyses of indomethacin versus ibuprofen versus placebo for PDA in preterm infants. Arch Dis Child Fetal Neonatal 164(3):135\u2013140","journal-title":"Arch Dis Child Fetal Neonatal"},{"key":"2830_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2431-6-15","volume":"6","author":"LCL Lee","year":"2006","unstructured":"Lee LCL, Tillett A, Tulloh R, Yates R, Kelsall W (2006) Outcome following patent ductus arteriosus ligation in premature infants: a retrospective cohort analysis. BMC Pediatr 6:15\u201321","journal-title":"BMC Pediatr"},{"issue":"6","key":"2830_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.pedneo.2012.08.011","volume":"53","author":"CH Lee","year":"2012","unstructured":"Lee CH, Chen HN, Tsao L (2012) Oral ibuprofen versus intravenous indomethacin for closure of patent ductus arteriosus in very low birth weight infants. Pediatr Neonatol 53(6):346\u2013353","journal-title":"Pediatr Neonatol"},{"issue":"6","key":"2830_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.amjcard.2008.11.044","volume":"103","author":"CC Lin","year":"2009","unstructured":"Lin CC, Hsieh KS, Huang TC, Weng KP (2009) Closure of large patent ductus arteriosus in infants. Am J Cardiol 103(6):857\u2013861","journal-title":"Am J Cardiol"},{"issue":"6","key":"2830_CR16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1096\/fj.04-2437fje","volume":"19","author":"R Lucas","year":"2005","unstructured":"Lucas R, Warner TD, Vojnovic I, Mitchell JA (2005) Cellular mechanisms of acetaminophen: role of cyclo-oxygenase. FASEB J 19(6):635\u2013637","journal-title":"FASEB J"},{"issue":"3","key":"2830_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1067\/mcp.2000.104736","volume":"67","author":"PT Manyike","year":"2000","unstructured":"Manyike PT, Kharasch ED, Kalhorn TF, Slattery JT (2000) Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin Pharmacol Ther 67(3):275\u2013282","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"2830_CR18","doi-asserted-by":"publisher","first-page":"F424","DOI":"10.1136\/adc.2007.118117","volume":"92","author":"PJ McNamara","year":"2007","unstructured":"McNamara PJ, Sehgal A (2007) Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed 92(6):F424\u2013F427","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2830_CR19","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00246-012-0182-2","volume":"33","author":"U Meibner","year":"2012","unstructured":"Meibner U, Charrabatry R, Topf HG, Rascher W, Schroth M (2012) Improved closure of patent ductus arteriosus with high doses of ibuprofen. Pediatr Cardiol 33:586\u2013590","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"2830_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000302719","volume":"99","author":"M Moll","year":"2011","unstructured":"Moll M, Goelz R, Naegele T, Poets CF (2011) Are recommended phototherapy thresholds safe enough for extremely low birth weight (ELBW) infants? A report on 2 ELBW infants with kernicterus despite only moderate hyperbilirubinemia. Neonatology 99(2):90\u201394","journal-title":"Neonatology"},{"issue":"3","key":"2830_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000345337","volume":"103","author":"MY Oncel","year":"2013","unstructured":"Oncel MY, Yurttutan S, Degirmencioglu H, Uras N, Altug N, Erdeve O, Dilmen U (2013) Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology 103(3):166\u2013169","journal-title":"Neonatology"},{"key":"2830_CR22","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jpeds.2013.11.008","volume":"164","author":"MY Oncel","year":"2014","unstructured":"Oncel MY, Yurttutan S, Erdeve O, Uras N, Altug N, Oguz SS, Canpolate FE, Dilmen U (2014) Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr 164:510\u2013514","journal-title":"J Pediatr"},{"issue":"2","key":"2830_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1517\/14740338.4.2.157","volume":"4","author":"S Peng","year":"2005","unstructured":"Peng S, Duggan A (2005) Gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Expert Opin Drug Safe 4(2):157\u2013169","journal-title":"Expert Opin Drug Safe"},{"key":"2830_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0022-3476(99)70093-4","volume":"135","author":"M Pezzati","year":"1999","unstructured":"Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF (1999) Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 135:733\u2013738","journal-title":"J Pediatr"},{"issue":"1","key":"2830_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1651-2227.2008.01007.x","volume":"98","author":"C Rheinlaender","year":"2009","unstructured":"Rheinlaender C, Helfenstein D, Walch E, Berns M, Obladen M, Koehne P (2009) Total serum bilirubin levels during cyclooxygenase inhibitor treatment for patent ductus arteriosus in preterm infants. Acta Paediatr 98(1):36\u201342","journal-title":"Acta Paediatr"},{"issue":"11","key":"2830_CR26","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s00431-015-2541-5","volume":"174","author":"DW Roofthooft","year":"2015","unstructured":"Roofthooft DW, van Beynum IM, de Klerk JC, van Dijk M, van den Anker JN, Reiss IK, Tibboel D, Simons SH (2015) Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure. Eur J Pediatr 174(11):1433\u20131440","journal-title":"Eur J Pediatr"},{"key":"2830_CR27","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jpeds.2006.01.047","volume":"148","author":"B Schmidt","year":"2006","unstructured":"Schmidt B, Roberts RS, Fanaroff A (2006) Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the trial of indomethacin prophylaxis in preterms (TIPP). J Pediatr 148:730\u2013734","journal-title":"J Pediatr"},{"key":"2830_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0090-6980(74)90042-2","volume":"8","author":"M Starling","year":"1974","unstructured":"Starling M, Elliott R (1974) The effects of prostaglandins, prostaglandin inhibitors, and oxygen on the closure of the ductus arteriosus, pulmonary arteries and umbilical vessels invitro. Prostaglandins 8:187\u2013203","journal-title":"Prostaglandins"},{"key":"2830_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1164\/ajrccm\/143.2.236","volume":"143","author":"JL Stefano","year":"1991","unstructured":"Stefano JL, Abbasi S, Pearlman SA, Spear ML, Esterly KL, Bhutani VK (1991) Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome. Effects of pulmonary compliance and ventilation. Am Rev Respir Dis 143:236\u2013239","journal-title":"Am Rev Respir Dis"},{"key":"2830_CR30","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1056\/NEJM200009073431001","volume":"343","author":"B Van Overmeire","year":"2000","unstructured":"Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Groote KD, Langhendries JP (2000) A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 343:674\u2013681","journal-title":"N Engl J Med"},{"key":"2830_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-1-4899-1810-9_27","volume-title":"Recent advances in prostaglandin, thromboxane, and leukotriene research. Advances in experimental medicine and biology","author":"JR Vane","year":"1997","unstructured":"Vane JR, Botting RM (1997) Mechanism of action of anti-inflammatory drugs. In: Sinzinger H, Samuelsson B, Vane JR, Paoletti R, Ramwell P, Wong PY-K (eds) Recent advances in prostaglandin, thromboxane, and leukotriene research. Advances in experimental medicine and biology. Plenum Press, New York, pp. 131\u2013138"},{"issue":"2","key":"2830_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12519-008-0017-7","volume":"4","author":"C Yang","year":"2008","unstructured":"Yang C, Lee J (2008) Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants. World J Pediatr 4(2):91\u201396","journal-title":"World J Pediatr"},{"issue":"8","key":"2830_CR33","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3109\/14767058.2012.755162","volume":"26","author":"S Yurttutan","year":"2013","unstructured":"Yurttutan S, Oncel MY, Arayici S, Uras N, Altug N, Erdeve O, Dilmen U (2013) A different first-choice drug in the medical management of patent ductus arteriosus: oral paracetamol. J Matern Fetal Neonatal Med 26(8):825\u2013827","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"2830_CR34","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1542\/peds.2008-2433","volume":"124","author":"E Zecca","year":"2009","unstructured":"Zecca E, Romagnoli C, De Carolis M, Costa S, Marra R, De Luca D (2009) Does ibuprofen increase neonatal hyperbilirubinemia? Pediatrics 124(2):480\u2013484","journal-title":"Pediatrics"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-016-2830-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-016-2830-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-016-2830-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T18:05:57Z","timestamp":1744135557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-016-2830-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,21]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["2830"],"URL":"https:\/\/doi.org\/10.1007\/s00431-016-2830-7","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,21]]},"assertion":[{"value":"13 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local Ethics Committee of Faculty of Medicine of our University and has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Informed consent was obtained from all parents of the participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}